Disease-specific Clinical Omics Datasets Software

Accelerating drug target identification, validation, and biomarker discovery

• Our disease-specific clinical omics datasets offer genomic data enriched with detailed clinical data and are statistically powered to distinguish signal from noise.

Powered for statistical significance

• Robust datasets with data from thousands of pseudonymized participants for many disease, subtypes, and clinical features. Population control dataset with data from 15,000 individuals.

Data privacy and privacy compliance

• All participant data are pseudonymized. Clinical, lifestyle, and genomic data provided to biotech partners are strictly access controlled.

Digitize your samples

• Whole Genome Sequencing from blood, serum, plasma, fresh tissue or FFPE samples.

Scalable GORdb platform

• A genomically-ordered architecture provides the freedom to query the genome in real-time and access private and public genomic databanks.

Powerful analytics crafted for genomics

• Analytics and AI trained on multi-omic and phenotypic data. Proven in target discovery, drug response signatures and population genomics.

Participant consent and re-contact

• Ability to re-contact participants for follow-up phenotypes, outcomes, and further samples. We ensure participant consent and compliance according to the highest standards of data protection and privacy.

• Partner with healthcare providers, biopharma, government, foundations, and patient groups
• Focus on homogeneous populations for better signal-to-noise resolution
• Use WGS to fully leverage the genome
• Disease specialists curate and validate deep phenotypic data
• Supported by our full catalog of products and team of experts